Thursday, October 23, 2014 10:26:27 AM
to announce a "new listing" of a "new" wholly-owned subsidiary (with no actual business, of course, and NOT an "uplist") in order to entice investors into his fledgling "Inner Core Group" IPO mill scheme.
The only winners in that scheme would be ICG, not the common holders of RIGH. Their cost, i.e., Sal's, Kelso's, USCoProducts, may have already been recouped by the share-dumping going on throughout 2014.
That is, assuming that neither IOWA, nor FINRA, nor the SEC catch up with Moffitt first:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106389626
Why else would Angel be withholding the actual totals for the FLOAT? (The last released figures are from 2012.)
Moffitt chose to list on the OTCBB because of its more lax requirements, higher perceived prestige, and its opaque trading platform (no electronic trades).
SEE:
http://en.wikipedia.org/wiki/OTC_Bulletin_Board
This would have given a veneer of respectability to the less-savvy investor, and allow for more backroom PAPER transactions.
The demise of the OTCBB kills THAT scheme and would force listing on the OTCQB (if it is done at al), which would necessitate a REVERSE SPLIT of from "1 for 25" to "1 for 35" AT A MINIMUM, probably much more.
See:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107394421
But that RS would probably be nothing compared to how common holders would/will be screwed when RIGH is Reverse-Mergered into a new sham company or taken over directly.
Remember, Sal & Co, and RIGH CEO Angel Stanz own over 90% of the fully diluted 65+BILLION shares.
As for "Paragrah 12", OTCQB has the same SEC-reporting requirements as the OTCBB:
http://www.otcmarkets.com/services/companies/otcqb/requirements
So enough mincing of words... just facts with links.
Angel's only plan is to cash himself out as best he can, RIGH shareholders be damned. Taylor Moffitt of Holydean is running the show here now.
All presented as opinion only. Certainly do your own Due Diligence.
Best to all.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM